[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340810-105":59,"doc-detail-340810-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","demonstrating-the-use-of-population-level-data-to-investigate-trends-in-the-rate-radiation-dose-and-cost-of-computed-tomography-across-clinical-groups-are-there-any-areas-of-concern","Demonstrating the use of population level data to investigate trends in the rate, radiation dose and cost of Computed Tomography across clinical groups - Are there any areas of concern?","","Introduction: Increases in computed tomography (CT) use may not always reflect clinical need or improve outcomes. This study demonstrates how population level data can identify variations in care between patient groups by analysing system-level changes in CT use around new diagnoses. Methods: A retrospective repeated cross-sectional study used linked West Australian administrative records for 504,723 adults diagnosed in 2006, 2012, and 2015. Results: CT use and costs rose for most conditions, while effective dose and lifetime attributable risk increased notably for respiratory, endocrine, and circulatory disorders. Conclusions: Findings flag areas needing deeper investigation into appropriateness and care value.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/demonstrating-the-use-of-population-level-data-to-investigate-trends-in-the-rate-radiation-dose-and-cost-of-computed-tomography-across-clinical-groups-are-there-any-areas-of-concern/340810/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/demonstrating-the-use-of-population-level-data-to-investigate-trends-in-the-rate-radiation-dose-and-cost-of-computed-tomography-across-clinical-groups-are-there-any-areas-of-concern/340810.png","ImageObject",300,407,{"name":92,"@type":93},"Ophelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-16","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main purpose of the study?","Question",{"text":112,"@type":113},"To demonstrate how population level data can be used to identify variations in care between patient groups by analysing system-level changes in CT use around new diagnoses.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was CT use and radiation risk assessed in the study?",{"text":117,"@type":113},"Using retrospective repeated cross-sectional analysis of linked West Australian administrative records, the study evaluated CT use (any and 2+ scans), effective dose, lifetime attributable risk of cancer incidence and mortality, and costs for 90 days before and after diagnosis.",{"name":119,"@type":110,"acceptedAnswer":120},"What trends were observed in CT use and costs across conditions?",{"text":121,"@type":113},"CT use increased for all conditions except neoplasms, and healthcare system costs increased for all conditions except neoplasms and mental disorders.",{"name":123,"@type":110,"acceptedAnswer":124},"Which clinical groups showed notable increases in effective dose and lifetime attributable risk?",{"text":125,"@type":113},"Effective dose increased substantially for respiratory and circulatory conditions, and lifetime attributable risk increased for endocrine and respiratory disorders.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},340810,1791938857,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","ORIGINAL ARTICLE  \nDemonstrating the use of population level data to investigate trends in the rate, radiation dose and cost of Computed Tomography across clinical groups: Are there any areas of concern?  \nSviatlana Kamarova, PhD 1,2,3 , David Youens, PhD 1,4 , Ninh T. Ha, PhD 1, Max Bulsara, PhD5,6, Jenny Doust, BMBS, PhD7, Richard Fox, PhD8, Marlene Kritz, PhD 1, Donald McRobbie, PhD9, Peter O’Leary, PhD 1,10,11, Paul M. Parizel, MD, PhD 12,13, John Slavotinek, MD 14, Cameron Wright, MD 1,8,15,16, & Rachael Moorin, PhD 1,6  \n1Health Economics and Data Analytics, Curtin School of Population Health, Faculty of Health Sciences, Curtin University, Bentley, Western Australia, Australia  \n2Sydney School of Health Sciences, The University of Sydney, Sydney, New South Wales, Australia  \n3Nepean Blue Mountains Local Health District, New South Wales Health, Kingswood, New South Wales, Australia  \n4Cardiovascular Epidemiology Research Centre, School of Population and Global Health, The University of Western Australia, Perth, Western Australia, Australia  \n5Institute for Health Research, University of Notre Dame, Notre Dame, Western Australia, Australia  \n6School of Population and Global Health, The University of Western Australia, Perth, Western Australia, Australia  \n7Australian Women and Girls’ Health Research (AWaGHR) Centre, School of Public Health, Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia  \n8Division of Internal Medicine, Medical School, Faculty of Health and Medical Sciences, The University of Western Australia, Perth, Western Australia, Australia  \n9School of Physical Sciences, University of Adelaide, Adelaide, South Australia, Australia  \n10Obstetrics and Gynaecology Medical School, Faculty of Health and Medical Sciences, The University of Western Australia, Perth, Western Australia, Australia  \n11PathWest Laboratory Medicine, QE2 Medical Centre, Nedlands, Western Australia, Australia  \n12Medical School, University of Western Australia, Perth, Western Australia, Australia  \n13Department of Radiology, Royal Perth Hospital, Perth, Western Australia, Australia  \n14SA Medical Imaging, SA Health and College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia 15Fiona Stanley Hospital, Murdoch, Western Australia, Australia  \n16School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, Tasmania, Australia  \nKeywords  \nComputed tomography, trends, utilisation  \nCorrespondence  \nDavid Youens, Health Economics & Data Analytics, Curtin School of Population Health, Faculty of Health Sciences, Curtin University, GPO Box U1987, Perth, Western Australia 6845, Australia. Tel: +61 08 9266 1590; Fax:  \n+61 08 9266 3636; E-mail: david.youens@ [curtin.edu.au](curtin.edu.au)  \nReceived: 7 December 2023; Accepted: 20 June 2024  \nJ Med Radiat Sci 72(Suppl. 2) (2025) S16–S30 doi: 10.1002/jmrs.811  \nAbstract  \nIntroduction: Increases in computed tomography (CT) use may not always reﬂect clinical need or improve outcomes. This study aimed to demonstrate how population level data can be used to identify variations in care between patient groups, by analysing system-level changes in CT use around the diagnosis of new conditions. Methods: Retrospective repeated cross-sectional observational study using West Australian linked administrative records, including 504,723 adults diagnosed with different conditions in 2006, 2012 and 2015. For 90 days pre/post diagnosis, CT use (any and 2+ scans), effective dose (mSv), lifetime attributable risk (LAR) of cancer incidence and mortality from CT, and costs were assessed. Results: CT use increased from 209.4 per 1000 new diagnoses in 2006 to 258.0 in 2015; increases were observed for all conditions except neoplasms. Healthcare system costs increased for all conditions but neoplasms and mental disorders. Effective dose increased substantially for respiratory (+2.5 mSv, +23.1%, P \u003C 0.001) and circulatory conditions (+2 . 1","cbCaiowykZVa0hAA","https://ap.wps.com/l/cbCaiowykZVa0hAA","pdf",386896,15,"English","# Introduction\n# Methods\n## Study design and data source\n# Results\n## CT utilisation trends\n## Effective dose and lifetime attributable risk\n## Costs by clinical group\n# Conclusions\n# Keywords","[{\"question\":\"What was the main purpose of the study?\",\"answer\":\"To demonstrate how population level data can be used to identify variations in care between patient groups by analysing system-level changes in CT use around new diagnoses.\"},{\"question\":\"How was CT use and radiation risk assessed in the study?\",\"answer\":\"Using retrospective repeated cross-sectional analysis of linked West Australian administrative records, the study evaluated CT use (any and 2+ scans), effective dose, lifetime attributable risk of cancer incidence and mortality, and costs for 90 days before and after diagnosis.\"},{\"question\":\"What trends were observed in CT use and costs across conditions?\",\"answer\":\"CT use increased for all conditions except neoplasms, and healthcare system costs increased for all conditions except neoplasms and mental disorders.\"},{\"question\":\"Which clinical groups showed notable increases in effective dose and lifetime attributable risk?\",\"answer\":\"Effective dose increased substantially for respiratory and circulatory conditions, and lifetime attributable risk increased for endocrine and respiratory disorders.\"}]","Demonstrating the use of population level data to investigate trends in the rate, radiation dose and cost of Computed Tomography across clinical groups - Are there any areas of concern? | PDF",1790038967,38,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fc142665a4e6ee7f1c41b94f96f8154a.webp",983,1291,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/23aa39e6e0595077d6de6864174efab3.webp",982,1290,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/171abae5e9a25238c1dcbfbc9ded6a2d.webp",981,1289,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dd66985cb064d8f5fcd467f8d2eb772c.webp",980,1287]